Transcranial magnetic stimulation has been FDA-cleared for major depressive disorder since 2008, and its use has expanded considerably since then. 

For most of that time, the clinical standard involved a relatively uniform protocol - the same stimulation frequency, the same brain target, and the same number of sessions applied to patients regardless of their individual neurobiology or clinical history. 

That approach produced meaningful results for many patients but left a substantial portion without adequate response. 

For patients in New York exploring their options, TMS in Brooklyn has become more accessible, giving people a local starting point before deciding between standard and more tailored approaches. 

The growing interest in personalized TMS treatment plans reflects a clinical recognition that one protocol does not fit every brain, and that the gap between responders and non-responders may partly be explained by how well the treatment was matched to the individual in the first place.

What Is Standard TMS and How Is It Delivered?

Standard TMS for depression targets the left dorsolateral prefrontal cortex using high-frequency repetitive stimulation, typically 10 Hz, delivered in a fixed protocol over four to six weeks. The total course involves 20 to 36 sessions, each lasting approximately 20 to 40 minutes depending on the protocol used.

The motor threshold, the amount of magnetic stimulation needed to produce a visible finger twitch, is used to calibrate the treatment intensity for each patient. This measurement varies between individuals and ensures the stimulation level is neither too weak nor excessive. 

Beyond this basic individualization, standard TMS applies the same parameters across patients: same target, same frequency, same session structure.

Standard protocols were built on population-level trial data, and they work for a meaningful proportion of patients. Response rates across real-world clinical data have generally ranged from 50 to 60 percent in treatment-resistant populations. 

For the patients who do not respond, the question is whether the standard approach was genuinely the wrong fit biologically - and whether a more tailored approach might have produced a different outcome.

What Are Personalized TMS Treatment Plans?

Personalized TMS treatment plans are individualized protocols designed around a patient's specific neurobiological profile, symptom presentation, and prior treatment history rather than applying a population-derived standard. 

TMS personalized treatment planning draws on multiple sources of information to determine the optimal stimulation target, frequency, intensity, and session structure for each individual.

What Goes Into Building a Personalized Plan

The components that distinguish a personalized TMS therapy plan from a standard one can include:

• Neuroimaging-guided targeting - functional MRI or connectivity mapping identifies the specific subregion of the prefrontal cortex most relevant to the patient's depressive network, rather than using a population average coordinate
• Symptom subtype consideration - patients with anxious depression, anhedonic depression, or comorbid PTSD may respond better to different targets or frequencies than the standard protocol addresses
• Coil type and depth of stimulation - deep TMS using H-coils reaches brain structures that standard figure-8 coils cannot, which is relevant for specific presentations including OCD
• Prior treatment response data - history of what has and has not worked, including previous TMS courses, guides protocol selection in ways a standard approach does not account for
• Session pacing and intensity adjustments - accelerated protocols, theta burst stimulation, and standard repetitive TMS are not interchangeable, and which format suits a patient depends on their clinical picture and tolerability

TMS personalized plans are not a separate treatment category - they use the same fundamental technology. The difference is in how systematically individual factors are integrated into the protocol decision rather than defaulted to population norms.

Why Does Brain Target Selection Matter So Much?

The left dorsolateral prefrontal cortex is the standard TMS target for depression, but this region is not a single anatomical point - it is an area with internal variation in its connectivity patterns. 

Research from Stanford, published in Nature Neuroscience in 2021, demonstrated that the antidepressant effects of TMS were significantly predicted by the specific subregion targeted and its connectivity with the subgenual anterior cingulate cortex. Patients whose treatment was aimed at the subregion most strongly connected to this circuit showed the greatest response.

This finding is the neurobiological basis for the shift toward personalized TMS treatment plans in more advanced clinical settings. Standard TMS uses a scalp measurement method, typically the 5.5 cm rule, to approximate the location of the dorsolateral prefrontal cortex. 

This method does not account for individual differences in brain anatomy or connectivity. Neuroimaging-guided targeting identifies the functionally relevant subregion for each patient rather than relying on an approximation that may be off by a clinically meaningful margin.

Not every clinic has access to the imaging infrastructure required for this level of targeting precision. But the principle, that target selection should be informed by individual neurobiology rather than population averages, underlies the broader rationale for TMS personalized treatment planning.

How Do Personalized TMS Plans Handle Stimulation Parameters?

Beyond targeting, personalized TMS therapy plans also address stimulation parameters, the frequency, intensity, and patterning of the magnetic pulses, in ways that standard protocols do not.

Standard TMS uses 10 Hz repetitive stimulation at the target site. Theta burst stimulation (TBS) delivers stimulation in shorter bursts that mimic naturally occurring brain rhythms and has been shown in a large non-inferiority trial published in The Lancet to produce comparable antidepressant effects to standard 10 Hz TMS in a fraction of the session time. 

Intermittent TBS, the excitatory variant, is now FDA-cleared and is increasingly used in accelerated protocols.

The choice between these stimulation formats is not arbitrary. Some patients tolerate standard repetitive TMS better than theta burst. 

Others have scheduling constraints that make accelerated TMS personalized plans the only practical option. Some presentations respond differently to the two approaches. 

A personalized protocol accounts for these factors rather than defaulting to whichever format the clinic uses most routinely.

What Does the Evidence Say About Personalized vs Standard TMS?

The evidence specifically comparing personalized TMS treatment plans to standard protocols in controlled trials is still developing, but several findings are worth noting.

The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol, an accelerated, imaging-guided, connectivity-targeted TMS approach, produced remission in 78.6 percent of participants with severe treatment-resistant depression in a randomized controlled trial published in the American Journal of Psychiatry in 2021. 

This was a small trial, and replication in larger samples is ongoing, but the magnitude of the effect compared to historical standard TMS data has generated significant clinical attention.

Real-world evidence also supports the value of tailoring. Patients who receive motor threshold recalibration throughout a TMS course, rather than a single baseline measurement, show better-maintained stimulation accuracy as their neural excitability changes during treatment. This is a simpler form of ongoing individualization that is within reach of most clinical settings.

Who Benefits Most From a Personalized TMS Therapy Plan?

Not every patient needs or has access to advanced neuroimaging-guided TMS. Standard protocols remain appropriate for many patients, particularly those presenting for a first TMS course without complex comorbidities.

The clinical profiles most likely to benefit from tms personalized plans include:

• Patients who have completed one or more standard TMS courses without adequate response
• Those with comorbid anxiety, PTSD, or OCD where different targets or coil types are indicated
• Patients with complex or atypical depression presentations where subtype-specific targeting may improve outcomes
• Those with scheduling constraints or tolerability concerns that make accelerated or theta burst formats more appropriate than standard 10 Hz protocols

Access to personalized TMS treatment plans varies significantly between settings. Academic medical centers and specialized TMS clinics are more likely to offer imaging-guided targeting and multiple protocol options than general psychiatry practices with a single TMS device. 

Patients who have not responded to standard TMS and are considering further treatment are in the strongest position to ask specifically about what individualization options are available at their treating facility.

Frequently Asked Questions 

How much does personalized TMS cost compared to standard TMS?

Standard TMS courses typically range from $6,000 to $12,000 out of pocket. Personalized protocols cost more due to neuroimaging and added clinical complexity. Insurance coverage for personalized approaches is less consistent than for standard TMS and worth confirming before starting.

How long does a personalized TMS course take compared to standard treatment?

Standard TMS runs four to six weeks of daily sessions. Accelerated personalized protocols can compress this into days. Others follow a similar timeline to standard TMS but with parameters adjusted throughout. The schedule is part of what gets individualized.

Are there side effects unique to personalized TMS?

Not significantly. Scalp discomfort, headache, and noise from the coil are common to both. Accelerated protocols may feel more fatiguing due to the condensed schedule. Deep TMS with H-coils reaches deeper structures and has a slightly different tolerability profile, though serious adverse events remain rare.

Can personalized TMS be used for conditions other than depression?

Yes. Different targets are being explored for OCD, PTSD, anxiety, and chronic pain. FDA clearance currently covers specific protocols for depression and OCD. Other applications remain investigational, though trial data is growing.

Does a patient need a referral to access personalized TMS?

In most settings, yes. A psychiatric evaluation is standard before any TMS course begins. Personalized protocols typically require referral to an academic center or specialist TMS clinic, though self-referral is possible in some private settings.